September 26, 2016 2:57 PM ET

Pharmaceuticals

Company Overview of Astellas Pharma, Inc.

Key Executives for Astellas Pharma, Inc.

NameBoard RelationshipsTitleAge
Yoshihiko Hatanaka No RelationshipsChief Executive Officer, President and Representative Director--
Yasumasa Masuda No RelationshipsChief Financial Officer and Senior Corporate Executive--
Percival Barretto-Ko No RelationshipsSenior Vice President of International Operations--
Masatoshi Kuroda No RelationshipsPresident of Asia & Oceania Business and Corporate Executive--
Yukio Matsui No RelationshipsPresident of EMEA Operations and Corporate Executive--
View More Key Executives

Astellas Pharma, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
There is no Board Members data available.

Astellas Pharma, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Compensation Committee Yutaka KaseNo Relationships2 Executives
Nominating Committee Yutaka KaseNo Relationships1 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$1.1M
1.1M
404.9K
Bonus$1.0M
1.0M
513.7K
Total Short Term Compensation$2.1M
2.1M
594.3K
Total Value of Options
14.4M
Compensation as of Fiscal Year
Astellas Pharma, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Endo International plc Announces Executive Changes
September 23, 2016 11:00 AM ET
Gujarat Themis Biosyn Ltd. Announces Board Changes
September 23, 2016 10:41 AM ET
Merck KGaA Appoints Isabel De Paoli as Chief Strategy Officer, Effective 1 October 2016
September 23, 2016 12:00 AM ET
Valeritas Holdings, Inc. Announces Board Changes, Effective October 10, 2016
September 22, 2016 12:00 PM ET
Lannett Company, Inc. Announces Resignation of Mahendra Dedhiya as Chief of Scientific Affairs
September 22, 2016 10:53 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Astellas Pharma, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.